Poliomyelitis
📧 Sign up to get email alerts when something new happens for Poliomyelitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-11-06Clinical Trial Update: To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years [Phase 3]
Phase 3 trial update evaluating immunogenicity and safety of DTaP-IPV vaccine as a booster in healthy children aged 4-6 years.
-
CLINICAL_TRIALS trial_result · 2020-09-01Clinical Trial Update: A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age [Phase 4]
Phase 4 trial evaluating safety and immunogenicity of tOPV in 1-5 years and at 6 weeks of age for poliomyelitis; completed with results post…
-
CLINICAL_TRIALS trial_result · 2020-08-18Clinical Trial Update: A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV [Phase 3]
Phase 3 trial evaluating immunogenicity of intramuscular full-dose and intradermal fractional-dose IPV; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of Oral Polio Vaccine Type 2 in Infants and Children [Phase 4]
A Phase 4 study evaluating safety and immunogenicity of oral polio vaccine type 2 in infants and children completed, with results posted in …
-
CLINICAL_TRIALS trial_result · 2020-06-24Clinical Trial Update: Sero-conversion Study for a Two-dose Schedule of Sabin IPV in China [Phase 4]
Phase 4 clinical trial update on a two-dose Sabin IPV schedule conducted in China; completed study evaluating seroconversion.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2020-06-24Clinical Trial Update: A Study of Immunogenicity and Seroconversion With Sabin IPV Schedules in China. [Phase 4]
Phase 4 trial evaluating immunogenicity and seroconversion with Sabin inactivated poliovirus vaccine schedules in China.
-
CLINICAL_TRIALS trial_result · 2020-04-07Clinical Trial Update: Persistence of IPV Immunity [Phase 4]
Phase 4 clinical trial assessing persistence of IPV immunity has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Immunogenicity and Safety of Liquid Bivalent Oral Poliomyelitis Vaccine [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of a liquid bivalent oral poliomyelitis vaccine has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-31Clinical Trial Update: IPV-102 Safety, Tolerability and Immunogenicity of TAK-195 in Healthy Infants, Toddlers and Adults [Phase 1, Phase 2]
A Phase 1/2 clinical trial assessing the safety, tolerability, and immunogenicity of IPV-102 (TAK-195) in healthy infants, toddlers, and adu…
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery [Phase 4]
Phase 4 trial evaluating immunogenicity and safety of a booster dose of Infanrix Hexa in healthy infants born to mothers vaccinated with Boo…
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age). [Phase 3]
Phase 3 immunogenicity and safety trial evaluating combined or separate vaccines against common childhood diseases in infants (2, 4, 6 month…
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of Monovalent OPV2 in Children Aged 1 to 5 Years in Lithuania [Phase 4]
Phase 4 trial assessing safety and immunogenicity of monovalent OPV2 in children aged 1 to 5 years in Lithuania has completed with posted re…
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Immunogenicity and Safety Evaluation of Different Sequential Immunization Strategies by Sabin IPV and bOPV in Chinese Infants [Phase 4]
Phase 4 trial evaluating immunogenicity and safety of sequential Sabin IPV and bOPV strategies in Chinese infants for polio.
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants [Phase 2]
Phase 2 study assessing safety and immunogenicity of a hexavalent DTwP-HepB-IPV-Hib vaccine in healthy infants; status not specified.
-
CLINICAL_TRIALS trial_result · 2019-08-29Clinical Trial Update: A Clinical Study to Evaluate the Safety and Immunogenicity of Inactivated Poliomyelitis Vaccine in Healthy Infants [Phase 2, Phase 3]
A clinical study evaluating safety and immunogenicity of an inactivated poliomyelitis vaccine in healthy infants completed Phase 2 and Phase…
-
CLINICAL_TRIALS trial_result · 2019-06-10Clinical Trial Update: Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery [Phase 4]
Phase 4 immunogenicity and safety study of Infanrix Hexa in healthy infants, including those born to mothers vaccinated during pregnancy or …
-
CLINICAL_TRIALS trial_result · 2019-04-03Clinical Trial Update: Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine. [Phase 2]
A Phase 2 clinical trial evaluating the safety and immunogenicity of a Sabin Inactivated Poliovirus Vaccine has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a "2+1"Sequential Schedule With bOPV in Infants [Phase 3]
A Phase 3 clinical trial evaluating the immunogenicity and safety of sIPV in a 2+1 sequential schedule with bOPV in infants has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a '1+2' Sequential Schedule With bOPV in Infants [Phase 3]
A Phase 3 trial evaluating the immunogenicity and safety of a Sabin inactivated poliovirus vaccine (sIPV) given in a 1+2 schedule with bOPV …
-
CLINICAL_TRIALS trial_result · 2019-01-29Clinical Trial Update: Trail To Evaluate the Immune Effects of Primary and Booster Immunizations With Poliovirus Vaccine [Phase 3]
Phase 3 clinical trial evaluating the immune effects of primary and booster immunizations with a poliovirus vaccine. The current status is u…
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine [Phase 3]
Phase 3 immunogenicity and safety study of Infanrix Hexa in infants completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: An Immunogenicity and Safety Study of Sabin Inactivated Poliovirus Vaccine (Vero Cell) in 2-month-old Infants [Phase 3]
Phase 3 trial assessing immunogenicity and safety of Sabin Inactivated Poliovirus Vaccine (Vero Cell) in 2-month-old infants; the study is c…
-
CLINICAL_TRIALS trial_result · 2019-01-09Clinical Trial Update: Comparison of Immunity Following IPV Versus fIPV: a Community Based Randomized Controlled Trial in Pakistan [Phase 4]
A Phase 4 randomized trial comparing immunity after IPV versus fIPV in a community setting in Pakistan.
-
CLINICAL_TRIALS trial_result · 2018-12-17Clinical Trial Update: Safety and Reactogenicity of GSK Biologicals' Inactivated Poliomyelitis Vaccine (IPV) (Poliorix) in Infants [Phase 1]
Phase 1 trial update on safety and reactogenicity of GSK's inactivated poliomyelitis vaccine (IPV) Poliorix in infants.
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given at 6, 10, 14 Weeks and 9 Months [Phase 3]
Phase 3 trial evaluating safety and immunogenicity of an adjuvanted reduced-dose inactivated polio vaccine given at 6, 10, 14 weeks and 9 mo…